Most Recent

image: Elder Pharmacology

Elder Pharmacology

By | January 1, 2014

Studying and treating the chronic diseases associated with aging needs serious revamping.

5 Comments

image: Lights, Camera, Action

Lights, Camera, Action

By | January 1, 2014

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

image: Neurons On Demand

Neurons On Demand

By | January 1, 2014

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

image: Outwitting the Perfect Pathogen

Outwitting the Perfect Pathogen

By | January 1, 2014

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

image: Flu Vaccine-Narcolepsy Link Explained?

Flu Vaccine-Narcolepsy Link Explained?

By | December 20, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

4 Comments

image: How HIV Destroys Immune Cells

How HIV Destroys Immune Cells

By | December 19, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

1 Comment

image: NIH Calls for BRAIN Proposals

NIH Calls for BRAIN Proposals

By | December 19, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

image: Enzyme Checks Neuronal Growth

Enzyme Checks Neuronal Growth

By | December 17, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

1 Comment

image: NIH Marks Millions for Brain Injury

NIH Marks Millions for Brain Injury

By | December 17, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

image: Inside Information

Inside Information

By | December 16, 2013

Studying and treating the chronic diseases associated with aging needs serious revamping.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech